Eledon Pharmaceuticals (ELDN) Accumulated Expenses (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Accumulated Expenses of $6.5 million for Q1 2026, up 9.15% year-on-year from $6.0 million in Q1 2025, and down 54.7% on a QoQ basis from $14.4 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Accumulated Expenses data on file, last reported at $6.5 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 9.15% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (up 9.15% YoY), and the FY2025 full-year result was $14.4 million, up 164.44% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $6.5 million, down from $14.4 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $14.4 million in Q4 2025 and bottomed at $845000.0 in Q1 2023.
- The 5-year median for Accumulated Expenses is $2.3 million (2023), against an average of $3.6 million.
- The widest annual swing landed in 2022, when Accumulated Expenses surged 1153.12%; it then tumbled 50.12% in 2025.
- A 5-year view of Accumulated Expenses shows it stood at $3.9 million in 2022, then slumped by 34.94% to $2.5 million in 2023, then surged by 113.36% to $5.4 million in 2024, then surged by 164.44% to $14.4 million in 2025, then tumbled by 54.7% to $6.5 million in 2026.
- The last three Accumulated Expenses figures came in at $6.5 million (Q1 2026), $14.4 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.50 Mn |
| Dec 31, 2025 | 14.36 Mn |
| Sep 30, 2025 | 3.21 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 5.96 Mn |
| Dec 31, 2024 | 5.43 Mn |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 969,000.00 |
| Dec 31, 2023 | 2.55 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 2.31 Mn |
| Mar 31, 2023 | 845,000.00 |
| Dec 31, 2022 | 3.91 Mn |
| Sep 30, 2022 | 1.28 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 2.22 Mn |
| Sep 30, 2021 | 783,000.00 |
| Jun 30, 2021 | 656,000.00 |
| Mar 31, 2021 | 128,000.00 |
| Dec 31, 2020 | 98,000.00 |
| Sep 30, 2020 | 50,000.00 |
| Jun 30, 2020 | 8,000.00 |
| Mar 31, 2020 | 953,000.00 |
| Dec 31, 2019 | 40,000.00 |
| Sep 30, 2019 | 415,000.00 |
| Jun 30, 2019 | 238,000.00 |
| Mar 31, 2019 | 2.59 Mn |
| Dec 31, 2018 | 742,000.00 |
| Sep 30, 2018 | 131,000.00 |
| Jun 30, 2018 | 135,000.00 |
| Mar 31, 2018 | 138,000.00 |
| Dec 31, 2017 | 111,000.00 |
| Sep 30, 2017 | 1.15 Mn |
| Jun 30, 2017 | 1.49 Mn |
| Mar 31, 2017 | 186,000.00 |
| Dec 31, 2016 | 113,000.00 |
| Sep 30, 2016 | 5.46 Mn |
| Jun 30, 2016 | 5.97 Mn |
| Mar 31, 2016 | 4.29 Mn |
| Dec 31, 2015 | 4.95 Mn |
| Sep 30, 2015 | 4.01 Mn |
| Jun 30, 2015 | 622,000.00 |
| Mar 31, 2015 | 2.32 Mn |
| Dec 31, 2014 | 3.48 Mn |
| Sep 30, 2014 | 2.48 Mn |
| Dec 31, 2013 | 436,000.00 |